VIDEO: Trial points to using non-TNF biologic when first anti-TNF drug fails

SAN FRANCISCO – Rheumatoid arthritis patients who did not respond to the first tumor necrosis factor inhibitor they tried had a higher rate of good or moderate response when they switched to a...